top of page
Executive Spotlights

Jérôme Marzinski Appointed as Chief Executive Officer

Oxford, UK, November 07, 2022 (B3C newswire) -- OxSonics Therapeutics, a clinical-stage company focused on transforming cancer treatment through SonoTran®, its ultrasound-based drug delivery platform, announces that it has appointed Jérôme Marzinski as its Chief Executive Officer with immediate effect.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page